Chemistry:4-Acetoxy-MET
 | |
| Clinical data | |
|---|---|
| Other names | 4-Acetoxy-MET; Metacetin; 4-Acetoxy-N-methyl-N-ethyltryptamine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C15H20N2O2 |
| Molar mass | 260.337 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-Acetoxy-MET (4-Acetoxy-N-methyl-N-ethyltryptamine), also known as metacetin or 4-AcO-MET, is a hallucinogenic tryptamine. It is the acetate ester of 4-HO-MET, and a homologue of 4-AcO-DMT. It is a novel compound with very little history of human use.[1] It is sometimes sold as a research chemical by online retailers.
It is expected that the compound is quickly hydrolyzed into the free phenolic 4-HO-MET by serum esterases, but human studies concerning the metabolic fate of this drug are lacking.[citation needed]
Legality
4-Acetoxy-MET is unscheduled in the United States. It may be considered an analogue of Psilocin, a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical purposes could be considered a crime under the Federal Analogue Act[citation needed]
4-Acetoxy-MET is a controlled substance in Switzerland under Verzeichnis E [2]
4-Acetoxy-MET is a Class A drug in the UK because it is an ester of the drug 4-HO-MET, which is a Class A drug under the tryptamine catch-all clause[3]
References
- ↑ "New psychoactive substances reported to the EMCDDA and Europol for the first time in 2009 under the terms of Council Decision 2005/387/JHA". https://www.emcdda.europa.eu/attachements.cfm/att_101538_EN_Annex%202.pdf.
- ↑ "Fedlex". https://www.fedlex.admin.ch/eli/cc/2011/363/de.
- ↑ "Misuse of Drugs Act 1971". 2021-08-15. https://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I.
pl:4-Acetoksy-N,N-dietylotryptamina
sv:4-acetoxy-DET
 |
